However, inhibitors to Epidermal growth factor receptor (EGFR) and MAP kinse-ERK kinase (MEK) (a downstream molecule in the EGFR pathway) did not change the elevated level of EREG in TSC skin tumor (21). This evidence concerns the gene MAP2K7 and tuberous sclerosis.